S32826 is widely used in the pharmaceutical industry to develop treatments for inflammation-related diseases and immune system disorders. It possesses properties that inhibit specific enzymes involved in the inflammatory process, making it a promising agent for treating rheumatoid arthritis, psoriasis, and other autoimmune conditions. Preliminary studies also demonstrate its efficacy in reducing pain and swelling in patients with chronic inflammation.

Additionally, S32826 is employed in scientific research to investigate immune system mechanisms and molecular-level inflammatory processes, aiding scientists in developing more effective new drugs with reduced side effects.